Are Doctors Treating More Thyroid Cancer Patients Than Necessary?
Low‑risk thyroid cancer patients often receive unnecessary radioactive iodine ablation and other aggressive treatments, leading to potential harm and unnecessary costs.
The study analyzed more than 32,000 thyroid cancer cases and found that approximately 25% of low‑risk patients received radioactive iodine ablation, indicating an overuse of this therapy.
Over‑treatment with radioactive iodine can cause long‑term side effects such as altered taste, secondary cancers, and social isolation, while adding significant financial burden to the health system.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma
- The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancer
- Improving predicted risk of recurrence using molecular profiling in papillary thyroid cancer
- Global Burden of Thyroid Cancer in Adults Age 15‑49 Years and Its Predictions: Findings From Global Burden of Disease Study 2021
- Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management